The Role of Glutathione Metabolism in Chronic Illness Development and Its Potential Use as a Novel Therapeutic Target Pizzorno, J
Retatrutide needs additional TRIUMPH trial results throughout 2026 before submitting for FDA approval in late 2026 or early 2027, with approval expected in late 2027 and launch in early 2028
Copper-tripeptide is only half-way proven at this point but there are definitely promising results about it
Saves time on manual computations and unit conversions (mg, mcg, IU)
In rat and human tissue, high signals for GHSR1a mRNA are found expressed in several hypothalamic nuclei, the pituitary, and the dentate gyrus of the hippocampus, with additional yet reduced signals in CA2 and CA3 of the hippocampus, the substantia nigra, the ventral tegmental area, and the median raphe nuclei (Guan et al., 1997
Accordingly, combining vitamins D3 and K2 may help promote stronger bones, an important factor in the prevention of age-related physical decline